Incannex Healthcare (IXHL) Enterprise Value (2020 - 2026)
Incannex Healthcare (IXHL) posted quarterly Enterprise Value of -$74.5 million for Q1 2026, down 1010.12% year-on-year from $8.2 million in Q1 2025, and down 7.66% on a QoQ basis from -$69.2 million in Q4 2025.
Incannex Healthcare (IXHL) Enterprise Value (2020 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Enterprise Value for 7 consecutive years, with -$74.5 million the latest figure, recorded in Q1 2026.
- Quarterly Enterprise Value fell 1010.12% year-over-year to -$74.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$74.5 million (down 1010.12% YoY) and the FY2025 annual result came in at -$15.0 million, down 154.9% from the prior year.
- Enterprise Value slipped to -$74.5 million in Q1 2026 per IXHL's latest filing, from -$69.2 million in the prior quarter.
- Over the last five years, Enterprise Value for IXHL reached as high as -$2.1 million in Q4 2024 and fell as low as -$74.5 million in Q1 2026.
- A 5-year average of -$28.9 million and a median of -$15.0 million in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value soared 85.58% — and 2025, when it tumbled 3198.38%.
- Year by year, Enterprise Value stood at -$41.4 million in 2022, then jumped by 64.87% to -$14.6 million in 2023, then surged by 85.58% to -$2.1 million in 2024, then tumbled by 3198.38% to -$69.2 million in 2025, then declined by 7.66% to -$74.5 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$74.5 million, -$69.2 million, and -$73.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | -74.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.50 Mn |
| Dec 31, 2025 | -69.20 Mn |
| Sep 30, 2025 | -73.30 Mn |
| Jun 30, 2025 | -15.04 Mn |
| Mar 31, 2025 | -6.71 Mn |
| Dec 31, 2024 | -2.10 Mn |
| Sep 30, 2024 | -3.63 Mn |
| Jun 30, 2024 | -5.90 Mn |
| Mar 31, 2024 | -9.31 Mn |
| Dec 31, 2023 | -14.55 Mn |
| Jun 30, 2023 | -22.12 Mn |
| Dec 31, 2022 | -41.42 Mn |
| Jun 30, 2022 | -37.50 Mn |
| Jun 30, 2021 | -9.16 Mn |
| Jun 30, 2020 | -3.69 Mn |